The meeting of the Board of Directors of the Company will be held on Saturday, 30th May, 2026 to transact the following business: 1. To consider and take on records the Audited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Ishita Drugs & Industries Ltd has scheduled a Board meeting on 30th May 2026 to consider and approve the audited financial results for the quarter and year ended 31st March 2026. The meeting will also review the Directors' Report, Corporate Governance Report, and Management Discussion and Analysis for the 33rd Annual General Meeting. Additionally, the Board will consider the re-appointment of Internal Auditors for 2026-27 and take on record Disclosure of Interest of Directors. The company has closed its trading window from 1st April 2026 until 48 hours after the results announcement.
This is a routine board meeting notice and does not contain any specific financial data or unexpected disclosures. Shareholders should expect the audited annual results announcement shortly after this meeting on 30th May 2026.